ICICI Prudential Pharma Healthcare and DiagnosticsFund
Direct · Growth ₹41.94
22 Apr 2026
NAV
24.1%
3Y CAGR
25.0%
5Y CAGR
23.9%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
3.68
Sharpe
-20.6%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.88 L | 26.8% | -23.4% | 108.1% |
| 3 Years | ₹36.00 L | ₹51.98 L | 25.2% | 2.5% | 44.5% |
| 5 Years | ₹60.00 L | ₹1.07 Cr | 24.7% | 16.0% | 33.6% |
Fund SIP vs NIFTY 50
| Duration | Fund XIRR | Benchmark CAGR | Difference |
|---|---|---|---|
| 1 Year | 26.8% | 1.9% | +24.9% |
| 3 Years | 25.2% | 11.7% | +13.5% |
| 5 Years | 24.7% | 11.3% | +13.4% |